Akari Therapeutics Plc (AKTX) Fundamentals

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system for the treatment of rare and orphan diseases. Its main product candidate includes Coversin, Coversin long acting and Coversin dual action. The firm earns majority of its revenues from United Kingdom. It operates mainly in United States and United Kingdom.
SHARE INFORMATION
Market Cap$ 38,609,340
Shares Outstanding74,449,171
Float73,129,871
Percent Float98.23%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.42
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions22
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months87,010
Institutional Holdings Percent17.2%
Institutional Sold Previous 3 Months5,900
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned1,319,300
TRADING INFO
52 Week High$ 1.61
52 Week Low$ 0.38
52 Week High Change$ -61.01
21 Day Moving Average$ 0.4977
21 Day Extended Moving Average$ 0.503884
50 Day Moving Average$ 0.5178
50 Day Extended Moving Average$ 0.524571
200 Day Moving Average$ 0.847553
200 Day Extended Moving Average$ 0.818106
10 Day Average Volume65,421
20 Day Average Volume74,759
30 Day Average Volume71,119
50 Day Average Volume68,304
Alpha-0.024008
Beta1.3221
Standard Deviation0.219708
R20.105289
7 Day Price Change$ 0.0286
7 Day Percent Change5.84%
21 Day Price Change$ 0.00
21 Day Percent Change0.0%
30 Day Price Change$ 0.0686
30 Day Percent Change15.24%
Month to Date Price Change$ 0.0487
Month to Date Percent Change10.36%
Quarter to Date Price Change$ 0.0487
Quarter to Date Percent Change10.36%
180 Day Price Change$ -0.5114
180 Day Percent Change-49.65%
200 Day Price Change$ -0.4614
200 Day Percent Change-47.08%
Year to Date Price Change$ 0.0487
Year to Date Percent Change10.36%

Akari Therapeutics Plc (AKTX) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book4.40
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio3.70
Leverage Ratio1.40
Quick Ratio2.70
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-1.40
Enterprise Value$ 28,701,162
Price to Sales0.00
Price to Free Cash-2.70
PE High Last 5 Years-1.50
Price To Book4.40
Price To Cash Flow0.00
PE Low Last 5 Years-1.60
Price to Tangible Book4.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-231.42
Return on Equity-371.99
Return on Capital-365.34

Akari Therapeutics Plc (AKTX) Profile

PROFILE INFO
Issue TypeAD
SEC TypeDR
AuditorBDO USA, LLP
CEORachelle Jacques
Emplyoees9
Last AuditUE
CIK0001541157
IndustryBiotechnology
SectorHealthcare
NAICS-
CONTACT INFO
Address75/76 Wimpole Street
London, W1G 9RT
Websitehttps://www.akaritx.com
Facsimile-
Telephone+44 2080040270
Emailpeter.vozzo@westwicke.com


Your Recent History
NASDAQ
AKTX
Akari Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.